SETDB2 and lymphoma: In addition, SETDB2 was also a glucocorticoid-induced putative epigenetic modifier that promotes the enrichment of glucocorticoid receptor chromatin, and glucocorticoids were found to inhibit the growth of lymphoma (43, 44).